Program Highlights

​Get a preview into the topics being discussed in the following sessions from the speakers who will be presenting:


​Parallel Session 1:
Systemic Autoimmune Diseases

​Monday 27 November 2017
10:40-12:40

Gabriela Medina, Mexico


Metabolic syndrome, autoimmunity and autoimmune rheumatic diseases

Metabolic syndrome (MetS) has increased in the last years throughout the world. Its prevalence is high among autoimmune rheumatic disease patients, leading to cardiovascular disease and consequently to death.

Mechanisms of interaction among MetS, autoimmunity and autoimmune rheumatic disease will be discussed, as well as preventive strategies.

Read more:
Medina G, Gutiérrez-Moreno AL, Vera-Lastra O, Saavedra MA, Jara LJ.Prevalence of metabolic syndrome in primary antiphospholipid syndrome patients. Autoimmun Rev. 2011;10: 214-7.
​Síndrome metabólico, autoinmunidad y enfermedades reumáticas autoinmunes

El síndrome metabólico se ha incrementado en los últimos años a través del mundo.Su prevalencia es elevada entre los pacientes con enfermedades reumáticas autoinmunes (ERA), originando enfermedad cardiovascular y consecuentemente la muerte.Mecanismos de interacción entre MetS, autoinmunidad y ERA se discutirán, así como las estrategias terapéuticas.

Lee Más:
Medina G, Gutiérrez-Moreno AL, Vera-Lastra O, Saavedra MA, Jara LJ.Prevalence of metabolic syndrome in primary antiphospholipid syndrome patients. Autoimmun Rev. 2011;10: 214-7.


​Parallel Session 4: Systemic Lupus Erythematosus

​Tuesday 28 November 2017
10:40-12:40

Jose A Gómez-Puerta, Colombia


​Urinary biomarkers in SLE

The knowledge of biomarkers is crucial for practicioners in charge of patiens with autoimmune diseases, including SLE.

Interest on the study of biomarkers in lupus is increasing during last years.

Our aim is to discuss the main urinary biomarkers related with lupus nephritis and to understand their clinical relevance and correlations with different classes of lupus nephritis on kidney biopsies.
Biomarcadores en la nefriris lúpica

El estudio de los diferentes biomarcadores en lupus ha despertado el interés de los investigadores durante los últimos años. El objetivo de la charla es discutir los principales biomarcadores en orina en la nefritid lúpica, su utilidad clínica y su correlación con las diferentes clases de nefritis lúpica en la biopsia renal.


Plenary Session 6: Advances in Autoimmune Disease Therapy 

Wednesday 29 November 2017
10:40-12:40


Simone Appenzeller, Brazil




Role of antibodies and cytokines in CNS manifestations in SLE

NP SLE is frequently observed and is a challange in clinical practice.

In this session, the role of antibodies and cytokines in NP SLE will be discussed.

Main mimickers of NP SLE will be presented. 








Keep Me Updated